Richard Francis
Verkställande Direktör på
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Förmögenhet: 39 M $ per 2026-06-30
Profil
Richard Francis is President, Chief Executive Officer & Director at Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. since 2023.
Mr. Francis is Director at Mettler-Toledo (Schweiz) GmbH since 2016 and Director at Purespring Therapeutics Ltd. since 2021.
Former roles include Chief Executive Officer & Division Head at Sandoz International GmbH from 2014 to 2019, Chief Executive Officer at Forcefield Therapeutics Ltd., Independent Director at Mettler-Toledo International, Inc. from 2016 to 2025, and Senior Vice President at Biogen, Inc. from 2006 to 2014.
Education includes an undergraduate degree from Manchester Metropolitan University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-05 | 1 177 529 ( 0,1 % ) | 39 M $ | 2026-06-30 |
Senaste nyheterna om Richard Francis
Aktiva positioner av Richard Francis
| Företag | Position | Start |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Verkställande Direktör | 2023-01-01 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Direktör/Styrelseledamot | 2023-01-01 |
Mettler-Toledo (Schweiz) GmbH
 Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Direktör/Styrelseledamot | 2016-05-01 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Verkställande Direktör | 2023-01-01 |
Tidigare kända positioner av Richard Francis
| Företag | Position | Slut |
|---|---|---|
| METTLER-TOLEDO INTERNATIONAL, INC. | Direktör/Styrelseledamot | 2025-05-01 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Verkställande Direktör | 2019-03-31 |
| BIOGEN INC. | Företagsledare/Principal | 2014-01-01 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Verkställande Direktör | - |
Richard Franciss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mettler-Toledo International, Inc.
 Mettler-Toledo International, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies precision instruments | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mettler-Toledo (Schweiz) GmbH
Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Producer Manufacturing |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
